Souhaitez-vous accéder aux communiqués récents ?

Vera Therapeutics to participate in the 44th Annual J.P. Morgan Healthcare Conference

MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Rio Tinto Exploration Canada Inc. (“RTEC”), is pleased to announce the results of...

Stephen (Steve) Griffin, Current Chief Financial Officer and Chief Operating Officer, Appointed President and Chief Executive OfficerCheryl Blanchard to Become Executive Chair of the Board of...

DUBLIN and BRIDGEWATER, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select...

Til Nasdaq Copenhagen 8. januar 2026 FASTSÆTTELSE AF KUPONRENTER         Fastsættelse af kuponrenter gældende fra den 12. januar 2026 Med virkning fra den 12. januar 2026 ændres kuponrenten på...

To Nasdaq Copenhagen 8 January 2026 FIXING OF COUPON RATES        Fixing of coupon rates effective from 12 January 2026 Effective from 12 January 2026, the coupon rates of floating-rate bonds...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026  Dosing ongoing in budoprutug Phase 1b/2a trial in ITP and Phase 1b trial in SLE; achieved...

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company”) is pleased to provide a review of 2025 corporate and technical...

VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR)  reports full year 2025 production of 6,486,661 silver...

Aclarion Provides 2025 Update and 2026 Corporate Outlook